Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Neuroendocrine Tumors,Radionuclide Imaging, Date of authorisation: 08/12/2016, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b9c421 ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

Case Medical Research ◽

10.31525/cmr-193042a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Movement Disorders ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors, Date of authorisation: 26/09/2017, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-f2339d ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors, Date of authorisation: 26/09/2017, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-f22274 ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Gastrointestinal Stromal Tumors,Carcinoma, Renal Cell,Neuroendocrine Tumors, Date of authorisation: 19/07/2006, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-8cd85e ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Renal Cell ◽

Gastrointestinal Stromal Tumors ◽

Assessment Report ◽

Stromal Tumors ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Gastrointestinal Stromal Tumors,Carcinoma, Renal Cell,Neuroendocrine Tumors, Date of authorisation: 19/07/2006, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-8d794b ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Renal Cell ◽

Gastrointestinal Stromal Tumors ◽

Assessment Report ◽

Stromal Tumors ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Radionuclide Imaging, Date of authorisation: 06/07/2016, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-838f1a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Axumin, fluciclovine (18F), Prostatic Neoplasms,Radionuclide Imaging, Date of authorisation: 21/05/2017, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-56e4d8 ◽

2019 ◽

Author(s):

Keyword(s):

Prostatic Neoplasms ◽

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Radionuclide Imaging,Alzheimer Disease, Date of authorisation: 20/02/2014, Revision: 14, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b07ad1 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer Disease ◽

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Carcinoid Tumor,Neuroendocrine Tumors, Date of authorisation: 17/09/2017, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-babd57 ◽

2019 ◽

Author(s):

Keyword(s):

Carcinoid Tumor ◽

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text